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Abstract
Population stratification is one of the major causes of spurious associations in association studies.
A unified association approach based on principal-component analysis can overcome the effect of
population stratification, as well as make use of both family and unrelated samples combined to
increase power (family-case-control, or FamCC). In this study, we compared FamCC and the
transmission-disequilibrium test (TDT) using data on hypertension, systolic blood pressure, and
diastolic blood pressure in the Framingham Heart Study. Our study indicated FamCC has
reasonable type I error for both the unrelated sample and the family sample for all three traits. For
these three traits, we found results from FamCC were inconsistent with those from the TDT. We
discuss the reasons for this inconsistency. After correcting for multiple tests, we did not detect any
significant single-nucleotide polymorphisms by either FamCC or the TDT.
Background
Population stratification is one of the major causes of
spurious associations in association studies. Several
approaches have been developed to deal with this
problem. The genomic control [1], structured association
[2,3], and principal-component analysis methods [4-8]
correct for population stratification in population-based
case-control studies by using a set of markers across the
genome. The transmission-disequilibrium test (TDT)
makes use of family structure to match the cases and
controls on their genetic background and thus avoids the
inflated type I error rate due to population stratification.
For a binary trait, it tests association by comparing the
frequencies of alleles transmitted and those of alleles not
transmitted from heterozygous parents to affected
children. A unified association method (family-case-
control, or FamCC), which utilizes both unrelated and
family samples, was developed based on principal-
component analysis [9]. The population background,
represented by the principal components, is calculated
from a large number of genetic markers typed on
unrelated subjects and family members, and then used
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can make use of both unrelated and family samples, this
method uses more information than the TDT. It has no
rare disease assumption, while accepting multiple
affected and unaffected siblings, which is a limitation
of another association method that combines family and
unrelated samples [10].
In this study, the unified association method FamCC [9]
and the TDT were compared for association tests of the
binary trait hypertension and quantitative traits systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
in the Framingham Heart Study data.
Methods
Samples
A total of 13,336 subjects in 1,231 pedigrees are
included in the Framingham Heart Study. They are
from three generations: the original generation, their
offspring, and the third generation. Subjects in the
original generation were discarded for this analysis
because of concern over the age of their DNA samples.
There are 6,395 genotyped and phenotyped subjects in
the offspring generation and the third generation, from
1,144 pedigrees, and they were all used as the family
sample for this association study. When the original
generation was discarded, some large pedigrees were
broken, which resulted in 1,705 nuclear families and
1,022 singletons. In order to determine how FamCC
would handle a completely unrelated sample, 1,109
biologically unrelated best genotyped individuals with
age greater than 20, single founders or founder couples,
were taken from the offspring generation of the family
sample to form a subsample of unrelated individuals.
Markers
There were 487,014 single-nucleotide polymorphisms
(SNPs) across the genome genotyped for each subject on
the Affymetrix 500k chip. In all, 22,775 SNPs on
chromosome 9 were used for our association study of
blood pressure because of the linkage evidence identified
on chromosome 9 in a previous study [11]. After
eliminating SNPs with more than 10% missing geno-
types, 20,266 SNPs remained. Then the SNPs with minor
allele frequency less than 5% or with Hardy-Weinberg
equilibrium test p-value < 2.47 × 10
6 were dropped,
resulting in 15,622 SNPs for the final analysis.
Blood pressure phenotypes
S B Pa n dD B Pw e r em e a s u r e df o rt h et w oc o h o r t s
(offspring and generation 3) at four examinations
(examination 1, examination 3, examination 5, and
examination 7). One binary trait, hypertension, and two
quantitative traits, SBP and DBP, were used as the
phenotypes in this study. Hypertension was defined as
having been treated for hypertension or if, at any of the
four examinations, SBP was higher than 140 mm Hg or
DBP was higher than 90 mm Hg. For the quantitative
S B Pa n dD B Pp h e n o t y p e s ,w ef i r s ta d d e d1 0m mH gt o
SBP and 5 mm Hg to DBP for individuals on hyperten-
sion treatment, as suggested by Tobin et al. [12]. Then for
SBP and DPB, adjustments were made for sex, age, BMI,
and cohort effects for each examination using multiple
linear regression. The average residuals over the four
examinations for SBP and DBP were used as the final SBP
and DBP phenotypes in the association analyses.
Statistical methods
FamCC first makes use of principal components to
adjust for population stratification, and then tests the
null hypothesis of no association. There are three steps in
FamCC [9]. In step 1, principal components are
generated from the marker data. In step 2, multiple
linear regression on the top 10 principal components is
performed for both the phenotypes and markers,
respectively, to estimate the coefficients in the linear
regression models. Because the principal components
represent genetic population diversity, linear regression
is aimed at adjusting out any population stratification.
In the first two steps, all the available unrelated
individuals in the data are used. In step 3, the residuals
of the phenotypes and the markers for each individual in
the data are calculated, and then association between the
phenotype and genotype is examined by testing the
correlations between these residuals.
In this study, we modified the association statistic in
FamCC when we calculated the variance of the correla-
tion between a marker genotype residual and phenotype
residual. We considered each family as a random draw
from a population and calculated the variance of the
correlation between genotype and phenotype among the
families. The genotype and phenotype correlation Tk for
the k
th family is Tg y kk j k j
j
nk
=
∗∗
= ∑
1
,w h e r e gkj
∗ and ykj
∗ are the
residuals of marker genotype and phenotype values for
individual j in the k
th family after adjusting for the
principal components, nk is the number of individuals in
the k
th family (nk = 1 for families of size one, namely, for
unrelated individuals, and nk > 1 for families with
multiple individuals). Define the statistic T as
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where N is the total number of families, and Nu is the
number of families of size one, that is, the number of
unrelated individuals. Thus, the statistic T has two parts,
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2 and σ f
2 are the variances of Tk for unrelated
individuals and families, respectively. They can be
estimated from the sample variance as
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Thus, estimating the pair-wise correlation between
family members for phenotype and genotype [9] is
now unnecessary.
The TDT was conducted with the family-based associa-
tion testing (FBAT) software [13], using the -e option to
test the null hypothesis of no association in the presence
of linkage (i.e., the alternative is the presence of both
association and linkage), in which the correlation among
sibling marker genotypes is adjusted by an empirical
variance-covariance estimator [14]. The additive genetic
model was assumed.
In this study, FamCC was used to analyze both the whole
family sample and the unrelated subsample. Note that
although the whole family sample was subjected to the
TDT analysis, only the data available in the 1,705 nuclear
families could be informative for that analysis.
Results
Figure 1 presents the p-value distributions for the SNPs
on chromosome 9 by the modified FamCC and the TDT,
in which no obvious deviation from the expected null
distribution was observed. The inflation factor l [15],
estimated by the mean of the test statistic values across
all the SNPs, was close to 1 for FamCC for all three traits
(Table 1), indicating that FamCC can control the
inflation of type I error well. FBAT also has good control
of type I error. As shown in Table 1, FamCC had
reasonable type I error at the nominal 0.05 level for all
three traits, the highest error rate being 0.053 for
hypertension using the unrelated subsample. The highest
type I error for FBAT was 0.055 for the phenotype DBP.
Table 2 presents SNPs identified by FamCC and FBAT
with p-values < 0.0001.
For hypertension, FamCC identified six SNPs using the
family sample; two of them also had p-values = 0.01 by
FamCC using the unrelated subsample. However, these
SNPs had p-values > 0.05 by FBAT. For SBP, FamCC
detected SNPs rs4979219 and rs10961684 using the
unrelated subsample and the family sample, respectively,
and FBAT detected SNP rs2583845. For DBP, FamCC
detected one SNP (rs1547761) using the family sample
that had a p-value 0.005 by FBAT. FBAT identified six
SNPs with p-values < 0.0001, and three of them had
p-values < 0.05 by FamCC using the family sample. Most
of the SNPs listed in Table 2 are located in gene desert
regions. Four SNPs are in linkage disequilibrium (LD)
a n da r el o c a t e do nt h eg e n ePRG-3,a n do n ei si nt h e
gene ABL1.
Discussion
We compared FamCC and the TDT for an association
study of hypertension in the Framingham Heart Study
data and found a number of interesting results.
The modified FamCC statistic, which does not require
estimating the pairwise genotype-phenotype correlations
between family members, has reasonable type I error
rates for both the family sample and the unrelated
subsample. Moreover, on checking the inflation factor
with FamCC for each trait, no obvious inflation of type I
error was observed. Using FamCC to identify genes
associated with hypertension, we found that although
there are several SNPs deviating from the expected null
distribution (Figure 1), four of these SNPs were in strong
LD, suggesting duplication of signals.
Using the same family sample, FamCC and FBAT
produced different levels of significance for the same
SNP in association testing of the three traits-hyperten-
sion, SBP, and DBP. Such differences also arose when
comparing FBAT and the generalized estimating equa-
tion approach in a study by Levy et al. [16]. These
inconsistent results reflect the different information used
by these two approaches and the fact that, because of
these different assumptions, it is the alternative hypoth-
eses that are different. For FBAT, the alternative hypoth-
esis is one of both linkage and association, while for
FamCC it is association only. FBAT, controls for
population stratification by comparing transmitted
with non-transmitted alleles from heterozygous parents,
ignoring the information in homozygous parents, while
FamCC applies principal components obtained from
marker genotype data to adjust for any stratification in
testing the null hypothesis of association only. FamCC
uses all the available phenotype and genotype data,
t h e r e f o r et h ee f f e c t i v es a m p l es i z ef o rt h eT D Tm e t h o di s
much smaller than that for FamCC, which would be
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by Zhu et al. [9]. Moreover, none of the detected SNPs
reached the 0.05 significance level after correcting for
multiple tests (corresponding to the nominal p-value
2 . 5×1 0
-6). Thus, the SNPs identified by both FamCC
and FBAT may only reflect the randomness of the
p-values under the null hypothesis. Because the informa-
tion used and the alternative hypotheses assumed by
FamCC and FBAT are not the same, observing incon-
sistent p-values from the two methods is not surprising.
Figure 1
Q-Q plots of the p-value distributions for FamCC and FBAT. The left column shows the plots from FamCC using the
unrelated subsample, the middle column are the plots from FamCC using the family sample, and the right column are the plots
from FBAT using the family sample. The three rows are respectively for hypertension, SBP and DBP. x axes, expected
distribution; y axes, observed distributions; the scale is -log10(p).
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In this study, we compared FamCC and the TDT using
data on hypertension, SBP, and DBP in the Framingham
Heart Study data. Our study indicated FamCC has
reasonable type I error. We observed inconsistent results
produced by FamCC and the TDT. The inconsistency can
be attributable to the fact these two methods are based
on different assumptions, and use different information.
These results may also reflect randomness of the p-values
of the two methods under the null hypothesis. However,
their performance, especially the power of the modified
FamCC and the TDT, should be further investigated by
simulation studies.
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Table 1: Inflation factor and type I error for FamCC and FBAT
Method Sample Inflation factor l Type I error (0.05 level)
a
Hypertension SBP DBP Hypertension SBP DBP
FamCC Unrelated subsample 1.03 1.01 1.02 0.053 0.049 0.051
FamCC Family sample 1.06 1.03 1 0.048 0.051 0.051
FBAT Family sample 1.00 0.98 1.02 0.051 0.046 0.055
aOn the assumption that all SNPs with p-values < 0.05 represent type I errors.
Table 2: SNPs on chromosome 9 identified by FamCC and FBAT with p-values < 0.0001
p-value
a
SNP Position (bp) Allele Freq. FamCC Unrelated
subsample
FamCC Family
sample
FBAT Family sample Gene
Hypertension
rs278714 75348574 0.06 0.01 7.24 × 10
-5 0.30 373 kb to ANXA1
rs368408 75355214 0.06 0.01 6.26 × 10
-5 0.26 380 kb to ANXA1
rs17761685 102914240 0.20 0.08 4.71 × 10
-5 0.40 PRG-3
rs17829436 102932851 0.18 0.19 4.65 × 10
-5 0.46 PRG-3
rs17829926 102944699 0.19 0.12 2.12 × 10
-5 0.54 PRG-3
rs4278208 102969600 0.19 0.11 1.02 × 10
-5 0.52 PRG-3
rs2984524 74179463 0.48 0.20 0.30 6.90 × 10
-5 10 kb to ZFAND5
SBP
rs4979219 109463841 0.16 8.52 × 10
-5 0.02 0.38 172 kb to KLF4
rs10961684 14718052 0.25 0.25 6.11 × 10
-5 0.75 5 kb to CER1
rs2583845 132603386 0.29 0.15 0.16 8.50 × 10
-5 ABL1
DBP
rs1547761 16908196 0.30 0.08 3.08 × 10
-5a 5.00 × 10
-3 40 kb to BNC2
rs7859491 121679109 0.10 0.70 0.10 5.70 × 10
-5 500 kb to DBC1, CDK5RAP2
rs3934946 121680170 0.10 0.71 0.06 2.70 × 10
-5 500 kb to DBC1, CDK5RAP2
rs41332646 121688986 0.10 0.90 0.04 4.10 × 10
-5 500 kb to DBC1, CDK5RAP2
rs10984755 121691216 0.10 0.91 0.04 3.00 × 10
-5 500 kb to DBC1, CDK5RAP2
rs10984756 121691605 0.10 0.90 0.07 2.80 × 10
-5 500 kb to DBC1, CDK5RAP2
rs10984758 121691719 0.10 0.73 0.04 2.40 × 10
-5 500 kb to DBC1, CDK5RAP2
aBold font indicates p-value <10
-4.
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